FDA: advisory committee on drugs for PTSD

Lundbeck announced that the US Food and Drug Administration plans to host a Psychopharmacologic Drugs Advisory Committee meeting to seek input on issues related to the Supplemental New Drug Application (sNDA) for brexpiprazole with sertraline to treat adults with post-traumatic stress disorder. PTSD can lead to later addiction.